October 2016

A large number of pharmaceutical companies across Europe had until June 30, 2016 to disclose their financial interactions with…

According to Politico, this morning Friday October 14, 2016 the MACRA final rule is being released by HHS. While the final…

As part of a three-part series on the Average Manufacturer Price (AMP), this month’s article explores the continuing and evolving…

On October 6, 2016, the U.S. Department of Health and Human Services announced its fourth Open Government Plan, which details…

On October 7, 2016, Mylan announced it reached an agreement with the United States Department of Justice (DOJ) to settle claims…

Within the pharmaceutical industry there are new operating models emerging. One form of emerging arrangement is the increasing use…

In September, FDA issued a draft guidance to clarify how it evaluates real-world data to determine whether it can be used in FDA…

As we have previously written, the topic of whether or not researchers should make all the data they collect when testing drugs…

The United States Food and Drug Administration (FDA) recently released its performance goals and procedures for fiscal years 2018…

On August 22, FDA and representatives from the medical device industry and laboratory community announced an agreement in…